AR and lung carcinoma: As expected, our quantification analyses were consistent with the IVIS signal observed earlier, demonstrating a higher number of metastatic foci in the shAR group compared to the control group, which could be attenuated in counterparts bearing lung cancer with depletion of both AR and circ-SLCO1B7 (Fig. 7B and C).